What is the market doing?
What the tape says about ALKS
Alkermes plc is +62% over the past year while the S&P 500 is +20%: 41 points ahead of the market.
+62%
1-year return · S&P 500 +20%
- vs 200-day average
- +25%
vs 200-day average · a clear uptrend
- RSI (14)
- 27
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 14%
Below its 52-week high
Details›
- Last close2026-09-08
- $45.49
- 1 monthS&P 500 −0.30%
- −6.0%
- 1 yearS&P 500 +20%
- +62%
- 5 yearsS&P 500 +85%
- +59%
- vs 50-day average$48.91
- −7.0%
- 52-week high
- $52.99
- 52-week low
- $26.52
- Annualised volatility
- 37%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$687K
| Year | Return |
|---|---|
| 2026 (year to date) | +63% |
| 2025 | −2.7% |
| 2024 | +3.7% |
| 2023 | +6.2% |
| 2022 | +12% |
| 2021 | +17% |
| 2020 | −2.2% |
| 2019 | −31% |
| 2018 | −46% |
| 2017 | −1.5% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +5.1% |
| Feb | 10 | 5 of 10 | +1.4% |
| Mar | 10 | 6 of 10 | −0.18% |
| Apr | 10 | 3 of 10 | −4.4% |
| May | 10 | 7 of 10 | +3.1% |
| Jun | 10 | 7 of 10 | +4.9% |
| Jul | 11 | 5 of 11 | −0.19% |
| Aug | 11 | 4 of 11 | −1.3% |
| Sep | 11 | 4 of 11 | −1.5% |
| Oct | 10 | 4 of 10 | −2.2% |
| Nov | 10 | 6 of 10 | +2.0% |
| Dec | 10 | 5 of 10 | +0.99% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #20 of 29 by Smart Score